| Consultant360

Research Summaries

FDA ALERT

FDA Approves Interchangeable Biosimilar for Psoriatic Arthritis, Other Inflammatory Conditions

11/30/2023

Anthony Calabro, MA

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

11/30/2023

research summary

Vitamin Supplementation During Treatment for Acute Myeloid Leukemia

11/30/2023

Leigh Precopio

Individuals with acute myeloid leukemia often have low levels of vitamin C and vitamin D at the time of diagnosis. Researchers examined how supplementation of these vitamins during treatment impacted...

11/30/2023

Research Summary

Semaglutide Provides Benefits for Patients With HFpEF and Obesity

11/22/2023

Anthony Calabro, MA

Researchers compared the effects of once-weekly semaglutide (2.4 mg) with a placebo during a 52-week period in patients with HFpEF and a BMI of 30 or higher.

11/22/2023

COVID-19 roundup

Outcomes Associated With Nirmatrelvir or Monupiravir, FDA Authorizes Use of Novavax Vaccines, and More

11/20/2023

Jessica Ganga

This COVID-19 roundup includes coverage on the outcomes associated with two omicron subvariant treatments, FDA’s authorization of Novavax vaccine, the NIH Treatment Guidelines Panel’s recommendation of...

11/20/2023

Research Summary

Can DNA Sequencing of Blood From Patients With AML in Remission Prior to HCT Identify Those At-Risk For Poor Outcomes?

11/17/2023

Anthony Calabro, MA

Researchers set out to determine whether DNA sequencing of the blood from adults with acute myeloid leukemia in remission before allogeneic hematopoietic cell transplant could detect residual variant...

11/17/2023

November 2023

Current Issue

November 2023

Volume 63

Issue 11